Skip to main content

Table 4 Cox univariable analysis for overall survival (OS) according to patient, tumour and treatment modalities characteristicsa

From: Clinical characteristics and prognosis of anal squamous cell carcinoma: a retrospective audit of 144 patients from 11 cancer hospitals in southern China

 

Univariable

Variable

HR (95%CI)

p

Age (years) (> 50 VS. ≤50)

2.90 (1.12–7.49)

0.028

Gender (Male VS. Female)

0.83 (0.33–2.13)

0.702

AJCC stage (III or IV VS. I or II)

4.56 (1.02–20.35)

0.046

T stage (T3 or T4 VS. T1 or T2)

2.33 (0.82–6.63)

0.113

N stage (N1-N3 VS. N0)

3.05 (1.07–8.74)

0.038

Tumor size (> 20 mm VS. ≤20 mm)

0.63 (0.24–1.65)

0.343

History of smoking (Yes VS. No)

1.13 (0.33–3.83)

0.848

Chemotherapy (Yes VS. No)

1.26 (0.46–3.46)

0.652

Radiotherapy (Yes VS. No)

0.81 (0.33–1.96)

0.634

Chemoradiotherapy (Yes VS. No)

0.74 (0.31–1.76)

0.488

  1. a: AJCC American Joint Committee on Cancer; HR Hazard ratio; CI Confidence interval; CRT Chemoradiotherapy